Philip Morris International Inc. (NYSE: PM) is reportedly exploring the sale of its cigar business for over $1 billion, ...

Philip Morris' premium valuations are justified by ZYN's FDA approval, smoke-free growth, and market dominance. See why PM ...

Investing.com -- Fitch Ratings revised its outlook for US tobacco company Philip Morris International, Inc. (NYSE: PM) to ...

The FDA approved the sale of Zyn nicotine pouches, which are increasingly popular with teens. But nicotine pouches cause addiction, as smoking and vaping also do.

The FDA’s... Investing.com -- Shares of Philip Morris International Inc. (NYSE:PM) rose 1% following the U.S. Food and Drug Administration's (FDA) authorization of 20 ZYN nicotine pouch ...

(RTTNews) - Philip Morris International Inc. (PM) Friday announced that a Canadian court has approved a settlement plan for its deconsolidated affiliate, Rothmans, Benson & Hedges Inc. or RBH ...

These undervalued stocks of high-quality companies are attractive investments today. We sell different types of products and services to both investment professionals and individual investors ...

Philip Morris International (PM) is looking to sell its U.S. cigar business for over $1 billion, Bloomberg reported. This potential sale is ...